Patrick Edwards

Patrick Edwards

Baker & McKenzie Services Limited


Patrick is a senior associate in the London office and part of the M&A team. Since joining Baker McKenzie as a trainee solicitor in 2014, Patrick has advised strategics and PE clients on a number of complex, high-value, cross-border and domestic transactions, with a focus on the healthcare and life sciences industry. Patrick is a member of Baker McKenzie's supply chain management team. Patrick was seconded to Baker McKenzie's New York office in 2016.

Representative Legal Matters

  • Acting on the divestment of Inceptua to Vesey Street Capital Partners.
  • Advising KKR (Health Care Strategic Growth Fund) on the acquisition of the wholesaler and manufacturer, CliniSupplies.
  • Advising Sandoz on the divestment of its China business to Aspen Pharma.
  • Acting for KKR (Health Care Strategic Growth Fund) on the acquisition of the CRO, Coriolis Pharma.
  • Acting for Sandoz on a long-term collaboration agreement with CRO, Just Evotec.
  • Acting for Takeda on the divestment of its Austrian manufacturing site to GTCR’s portco Corza Medical.
  • Advising Baxter on the spin-out of its kidney product division, Vantive.
  • Advising Johnson & Johnson on the spin-out of its consumer health division, Kenvue.
  • Advising Ingram Micro on the USD 3 billion divestment of its Commerce & Lifecycle Services division to Ceva Logistics (CMA CGM).
  • Acting for ICU Medical on its USD 2.7 billion acquisition of Smiths Medical.

Professional Honors

  • Lord Haldane Scholarship, The Honourable Society of Lincoln’s Inn
  • Hardwicke Entrance Prize, The Honourable Society of Lincoln’s Inn

Professional Associations and Memberships

  • Law Society of England and Wales


  • England & Wales~United Kingdom (2016)


  • University of Law (Legal Practice Course, Distinction) (2014)
  • City, University of London (Graduate Diploma in Law, Commendations) (2012)
  • University of Warwick (BSc Philosophy, Politics and Economics) (2011)